£106.38

This is the most expensive it has ever been. Walk away.

£106 today · previous high £106 · all-time low £102

Elsevier Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 63 days · 63 data points (no recent data)

Historical
Generating forecast…
£106.38 £101.33 £102.43 £103.53 £104.64 £105.74 £106.84 25 July 2026 09 August 2026 25 August 2026 09 September 2026 25 September 2026
View at Amazon ↗

Price data last checked 28 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 63 days • 4 price levels

Days at Price
Current Price
52 days 3 days 7 days 1 day · current 0 13 26 39 52 £102 £103 £104 £106 Days at Price

Price Analysis

Most common price: £102 (52 days, 82.5%)

Price range: £102 - £106

Price levels: 4 different prices over 63 days

Description
Early Detection of Alzheimer’s Disease: Biological and Technological Advances aims to introduce to a wide audience the high global priority problem of detecting AD prior to dementia onset. According to the Alzheimer’s Association, 5.8 million Americans are living with Alzheimer’s and care costs will cost the nation approximately $290 billion (2019 Alzheimer’s Disease Facts and Figures). With the failure of recent AD drug trials, many hypothesize that by the time symptoms appear, it is too late to be treated. Early detection can offer benefits such as more choice of medications, ability to participate in clinical trials, more time for family and for care planning. This book outlines potential solutions to the above problem using opportunities arising from the technology revolution, advances in neuroscience, and molecular biology. Most importantly, it discusses a paradigm shift from a reactive to a proactive diagnostic approach, aiming to detect disease before occurrence of symptoms. Topics covered include the use of sensing technologies (e.g. smartphones, smartwatches, Internet of Things) to detect early disease-related changes, the application of data science (machine learning/AI) to extract otherwise invisible disease features from these datasets and the potential to personalize diagnosis based on tracking changes in individual behaviours. Advances in blood-based biomarkers, brain imaging, and the potential for early diagnosis to aid interventions (lifestyle, dietary, pharmacological) to delay future development of dementia are also discussed. Outlines the importance of early diagnosis of Alzheimer’s Disease Helps readers understand the limitations of current clinical approaches and the need for a paradigmatic shift in diagnostic practice Discusses the potential role of technology in clinical practice using machine learning and artificial intelligence and the potential to personize diagnosis and treatment

Product Specifications
Brand
Elsevier
Format
paperback
ASIN
0128222409
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain
Amazon UK
Release Date
27 March 2025
Listed Since
13 December 2019

Barcode

No barcode data available

Similar Products You Might Like

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
97% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.07 12 Sep 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
97% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£58.28 25 Sep 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
97% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£12.97 18 Sep 2026
Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)
97% match

Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)

Elsevier

£55.49 06 Sep 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.82 24 Sep 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Elsevier

£90.99 25 Sep 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£122.62 24 Sep 2026
Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1
96% match

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

£91.56 18 Sep 2026
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
96% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Elsevier

£111.99 26 Aug 2026
Alzheimer's Disease Decoded: The History, Present, And Future Of Alzheimer's Disease And Dementia (second Edition)
96% match

Alzheimer's Disease Decoded: The History, Present, And Future Of Alzheimer's Disease And Dementia (second Edition)

World Scientific Publishing Company

£53.47 20 Sep 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Elsevier

£114.89 11 Sep 2026
Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)
96% match

Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)

Elsevier

£55.93 18 Sep 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 30 Sep 2026
Alzheimer’s Disease Estimation: A Pattern Recognition based Approach using MRI and Genotype Data
96% match

Alzheimer’s Disease Estimation: A Pattern Recognition based Approach using MRI and Genotype Data

LAP Lambert Academic Publishing

£63.00 18 Sep 2026
Clinical Diagnosis and Management of Alzheimer's Disease
96% match

Clinical Diagnosis and Management of Alzheimer's Disease

CRC Press

£151.26 28 Aug 2026
The Neuropsychology of Cortical Dementias (Contemporary Neuropsychology)
96% match

The Neuropsychology of Cortical Dementias (Contemporary Neuropsychology)

Springer Publishing Company

£76.70 19 Sep 2026
Neuroanatomy and Pathology of Sporadic Alzheimer's Disease: 215 (Advances in Anatomy, Embryology and Cell Biology, 215)
96% match

Neuroanatomy and Pathology of Sporadic Alzheimer's Disease: 215 (Advances in Anatomy, Embryology and Cell Biology, 215)

Springer

£57.43 30 Sep 2026
Genetics and Alzheimer’s Disease: Colloque Medecine et Recherche 2. Meeting Paris 1988 (Research and Perspectives in Alzheimer's Disease)
96% match

Genetics and Alzheimer’s Disease: Colloque Medecine et Recherche 2. Meeting Paris 1988 (Research and Perspectives in Alzheimer's Disease)

Springer

£82.00 24 Sep 2026
The End of Alzheimer's: The Brain and Beyond
96% match

The End of Alzheimer's: The Brain and Beyond

Elsevier

£50.89 21 Sep 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£154.94 04 Sep 2026